pI: 9.6158 |
Length (AA): 439 |
MW (Da): 52208 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_128560)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G17250 | protein NUCLEOLAR COMPLEX ASSOCIATED 4 |
Babesia bovis | BBOV_II005130 | hypothetical protein |
Brugia malayi | Bm1_46420 | Hypothetical 58.5 kDa protein T20B12.3 in chromosome III |
Candida albicans | CaO19.9458 | similar to essential nucleolar protein |
Candida albicans | CaO19.1902 | similar to essential nucleolar protein |
Caenorhabditis elegans | CELE_T20B12.3 | Protein T20B12.3 |
Dictyostelium discoideum | DDB_G0275403 | hypothetical protein |
Drosophila melanogaster | Dmel_CG2875 | CG2875 gene product from transcript CG2875-RC |
Echinococcus granulosus | EgrG_000535800 | nucleolar complex protein 4 |
Entamoeba histolytica | EHI_083570 | nuclear complex protein 4, putative |
Entamoeba histolytica | EHI_070740 | CBF/Mak21 family |
Echinococcus multilocularis | EmuJ_000535800 | nucleolar complex protein 4 |
Homo sapiens | ENSG00000184967 | nucleolar complex associated 4 homolog (S. cerevisiae) |
Leishmania braziliensis | LbrM.20.0670 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_340780.1 | CBF/Mak21 family, putative |
Leishmania infantum | LinJ.34.0780 | hypothetical protein, conserved |
Leishmania major | LmjF.34.0740 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.33.0740 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_01903 | hypothetical protein |
Mus musculus | ENSMUSG00000033294 | nucleolar complex associated 4 homolog (S. cerevisiae) |
Neospora caninum | NCLIV_010500 | hypothetical protein |
Oryza sativa | 4336790 | Os04g0585300 |
Onchocerca volvulus | OVOC8856 | Nucleolar complex protein 4 homolog |
Saccharomyces cerevisiae | YPR144C | Noc4p |
Schistosoma japonicum | Sjp_0007010 | similar to Uncharacterized protein C1604.06c, putative |
Schistosoma mansoni | Smp_017640 | nucleolar complex protein |
Trypanosoma brucei gambiense | Tbg972.4.3630 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.4.3670 | CBF/Mak21 family, putative |
Trypanosoma congolense | TcIL3000_4_3170 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.506201.110 | CBF/Mak21 family, putative |
Trypanosoma cruzi | TcCLB.509633.10 | CBF/Mak21 family, putative |
Toxoplasma gondii | TGME49_319662 | histone lysine methyltransferase, SET, putative |
Theileria parva | TP04_0054 | hypothetical protein |
Trichomonas vaginalis | TVAG_160960 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.4.3670 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.3670 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.3670 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.4.3670 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_T20B12.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_T20B12.3 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_T20B12.3 | Caenorhabditis elegans | slow growth | wormbase |
CELE_T20B12.3 | Caenorhabditis elegans | sterile | wormbase |
YPR144C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_319662 | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.